Non-Cystic Fibrosis Bronchiectasis (NCFB) is a chronic lung disease with currently no FDA-approved treatment. Patients suffer from persistent cough, excess sputum production and frequent respiratory infections.
NCFB is characterized by dilated airways inflamed with thick phlegm. Some patients suffer exacerbations, sudden severe flare-ups of symptoms that often require hospitalization and cause further permanent damage to the lungs.
Currently, no treatments are specifically approved in the US for this condition and physicians currently use bronchodilators, antibiotics, steroids, mucus thinners and surgery to treat patients.
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition without a cure. It damages the airways and lungs, leading to debilitating breathlessness.
Cystic fibrosis (CF) is a potentially fatal genetic disease characterized by the build-up of thick, sticky mucus and infection that can damage many of the body’s organs.
Asthma is a common chronic inflammatory disease that makes it harder to move air in and out of the lungs.
We welcome inquires from healthcare professionals seeking to learn more.